259
Views
3
CrossRef citations to date
0
Altmetric
Cornea

Correlation of Staphylococcus Epidermidis Phenotype and Its Corneal Virulence

, , ORCID Icon, ORCID Icon &
Pages 638-647 | Received 26 Jun 2020, Accepted 12 Sep 2020, Published online: 23 Nov 2020

References

  • Widerström M, Wiström J, Sjöstedt A, Monsen T. Coagulase-negative staphylococci: update on the molecular epidemiology and clinical presentation, with a focus on Staphylococcus epidermidis and Staphylococcus saprophyticus. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol. 2012;31(1):7–20. doi:10.1007/s10096-011-1270-6.
  • Vuong C, Otto M. Staphylococcus epidermidis infections. Microbes Infect. 2002;4(4):481–89. doi:10.1016/S1286-4579(02)01563-0.
  • von Eiff C, Peters G, Heilmann C. Pathogenesis of infections due to coagulase negative staphylococci. Lancet Infect Dis. 2002;2(11):677–85. doi:10.1016/S1473-3099(02)00438-3.
  • Otto M. Staphylococcus epidermidis–the ‘accidental’ pathogen. Nat Rev Microbiol. 2009;7:555–67.
  • Otto M. Molecular basis of Staphylococcus epidermidis infections. Semin Immunopathol. 2012;34(2):201–14. doi:10.1007/s00281-011-0296-2.
  • Wenbo H, Sun X, Wang Z, Zhang Y. Biofilm-forming capacity of Staphylococcus epidermidis, Staphylococcus aureus, and Pseudomonas aeruginosa from ocular infections. Invest Ophthalmol Vis Sci. 2012;53(9):5624–31. doi:10.1167/iovs.11-9114.
  • Patel J, Colton E, Ebert M, Anderson J. Gene expression during S. epidermidis biofilm formation on biomaterials. J Biomed Mater Res A. 2012;100(11):2863–69. doi:10.1002/jbm.a.34221.
  • Valour F, Trouillet-Assant S, Rasigade J, Lustig S, Chanard E, Meugnier H, Tigaud S, Vandenesch F, Etienne J, Ferry T, et al. Staphylococcus epidermidis in orthopedic device infections: the role of bacterial internalization in human osteoblasts and biofilm formation. PloS One. 2012;8(6):e67240: 1–11.
  • Toba F, Akashi H, Arrecubieta C, Lowy F. Role of biofilm in Staphylococcus aureus and Staphylococcus epidermidis ventricular assist device driveline infections. J Thorac Cardiovasc Surg. 2011;141(5):1259–64. doi:10.1016/j.jtcvs.2010.07.016.
  • Nayak N, Satpathy G, Nag H, Venkatesh P, Ramakrishnam S, Nag T, Prasad S. Slime production is essential for the adherence of Staphylococcus epidermidis in implant-related infections. J Hosp Infect. 2011;77(2):153–56. doi:10.1016/j.jhin.2010.09.023.
  • Llovet F, de Rojas V, Interlandi E, Martin C, Cobo-Soriano R, Ortega-Usobiaga J, Baviera J. Infectious keratitis in 204 586 LASIK procedures. Ophthalmology. 2009;117(2):232–238.e1–4. doi:10.1016/j.ophtha.2009.07.011.
  • Wahl J, Katz H, Abrams D. Infectious keratitis in Baltimore. Ann Ophthalmol. 1991;23:234–37.
  • McClellan K, Bernard P, Billson F. Microbial investigations in keratitis at the Sydney eye hospital. Aust N Z J Ophthalmol. 1989;17(4):413–16. doi:10.1111/j.1442-9071.1989.tb00564.x.
  • Stefan C, Nenciu A. Post-traumatic bacterial keratitis–a microbiological prospective clinical study. Oftalmol Buchar Rom 1990. 2006;50:118–22.
  • McCulley J, Dougherty J, Deneau D. Classification of chronic blepharitis. Ophthalmology. 1982;89(10):1173–80. doi:10.1016/S0161-6420(82)34669-2.
  • Donnenfeld E, O’Brien T, Solomon R, Perry H, Speaker M, Wittpenn J. Infectious keratitis after photorefractive keratectomy. Ophthalmology. 2003;110(4):743–47. doi:10.1016/S0161-6420(02)01936-X.
  • Wu P, Zhu H, Thakur A, Willcox M. Comparison of potential pathogenic traits of staphylococci that may contribute to corneal ulceration and inflammation. Aust N Z J Ophthalmol. 1999;27(3–4):234–36. doi:10.1046/j.1440-1606.1999.00192.x.
  • Nayak N, Satpathy G. Slime production as a virulence factor in Staphylococcus epidermidis isolated from bacterial keratitis. Indian J Med Res. 2000;111:6–10.
  • Nayak N, Satpathy G, Vajpayee R, Mrudula S. Phenotypic and plasmid pattern analysis of Staphylococcus epidermidis in bacterial keratitis. Indian J Ophthalmol. 2007;55(1):9–13. doi:10.4103/0301-4738.29488.
  • Sharifinejad M, Shokatpour N, Farnaghi F, Abedinyfar Z, Amoli F, Doustdar F. Different genotypes of adhesion operon genes in Staphylococcus epidermidis isolates from various ocular infections. Eye Contact Lens. 2018;44(Suppl 2):S277–S280. doi:10.1097/ICL.0000000000000464.
  • Fleiszig S, Evans D, Mowrey-McKee M, Payor R, Zaidi T, Vallas V, Muller E, Pier G. Factors affecting Staphylococcus epidermidis adhesion to contact lenses. Optom Vis Sci Off Publ Am Acad Optom. 1996;73(9):590–94. doi:10.1097/00006324-199609000-00005.
  • Sugita J, Yokoi J, Fullwood N, Quantock A, Takada Y, Nakamura Y, Kinoshita S. The detection of bacteria and bacterial biofilms in punctal plug holes. Cornea. 2001;20(4):362–65. doi:10.1097/00003226-200105000-00005.
  • Dougherty J, McCulley J, Silvany R, Meyer D. The role of tetracycline in chronic blepharitis. Inhibition of lipase production in staphylococci. Invest Ophthalmol Vis Sci. 1991;32:2970–75.
  • Martinez-Garcia S, Rodriguez-Martinez S, Cancino-Diaz M, Cancino-Diaz J. Extracellular proteases of Staphylococcus epidermidis: roles as virulence factors and their participation in biofilm. APMIS. 2018;126:177–85.
  • Twining S, Kirschner S, Mahnke L, Frank D. Effect of Pseudomonas aeruginosa elastase, alkaline protease, and exotoxin A on corneal proteinases and proteins. Invest Ophthalmol Vis Sci. 1993;34:2699–712.
  • Marquart M, Caballero A, Chomnawang M, Thibodeaux B, Twining S, O’Callaghan R. Identification of a novel secreted protease from Pseudomonas aeruginosa that causes corneal erosions. Invest Ophthalmol Vis Sci. 2005;46(10):3761–68. doi:10.1167/iovs.04-1483.
  • O’Callaghan R, Engel L, Hobden J, Callegan M, Green L, Hill J. Pseudomonas keratitis. The role of an uncharacterized exoprotein, protease IV, in corneal virulence. Invest Ophthalmol Vis Sci. 1996;37:534–43.
  • Tang A, Caballero A, Marquart M, O’Callaghan R. Pseudomonas aeruginosa small protease (PASP), a keratitis virulence factor. Invest Ophthalmol Vis Sci. 2013;54(4):2821–28. doi:10.1167/iovs.13-11788.
  • Tang A, Marquart M, Fratkin J, McCormick C, Caballero A, Gatlin H, O’Callaghan R. Properties of PASP: a Pseudomonas protease capable of mediating corneal erosions. Invest Ophthalmol Vis Sci. 2009;50(8):3794–801. doi:10.1167/iovs.08-3107.
  • Caballero A, Thibodeaux B, Marquart M, Traidej M, O’Callaghan R. Pseudomonas keratitis: protease IV gene conservation, distribution, and production relative to virulence and other Pseudomonas proteases. Invest Ophthalmol Vis Sci. 2004;45(2):522–30. doi:10.1167/iovs.03-1050.
  • Marquart M, O’Callaghan R. Infectious keratitis: secreted bacterial proteins that mediate corneal damage. J Ophthalmol. 2013. 369094 Epub. doi:10.1155/2013/369094.
  • O’Callaghan R, Callegan M, Moreau J, Green L, Foster T, Hartford O, Engel L, Hill J. Specific roles of alpha-toxin and beta-toxin during Staphylococcus aureus corneal infection. Infect Immun. 1997;65(5):1571–78. doi:10.1128/IAI.65.5.1571-1578.1997.
  • Supersac G, Piémont Y, Kubina M, Prévost G, Foster T. Assessment of the role of gamma-toxin in experimental endophthalmitis using a hlg-deficient mutant of Staphylococcus aureus. Microb Pathog. 1998;24(4):241–51. doi:10.1006/mpat.1997.0192.
  • Arana A, Bierdeman M, Balzli C, Tang A, Caballero A, Patel R, O’Callaghan R. Staphylococcus alpha-toxin action on the rabbit iris: toxic effects and their inhibition. Curr Eye Res. 2015;40(8):830–38. doi:10.3109/02713683.2014.959609.
  • Bierdeman M, Torres A, Caballero A, Tang A, O’Callaghan R. Reactions with antisera and pathological effects of Staphylococcus aureus gamma-toxin in the cornea. Curr Eye Res. 2017;42(8):1100–07. doi:10.1080/02713683.2017.1279636.
  • McCormick C, Caballero A, Balzli C, Tang A, O’Callaghan R. Chemical inhibition of alpha-toxin, a key corneal virulence factor of Staphylococcus aureus. Invest Ophthalmol Vis Sci. 2009;50(6):2848–54. doi:10.1167/iovs.08-3157.
  • Dajcs J, Thibodeaux B, Girgis D, O’Callaghan R. Corneal virulence of Staphylococcus aureus in an experimental model of keratitis. DNA Cell Biol. 2002;21:375–82.
  • Nemoto T, Ohara-Nemoto Y, Ono T, Kobayakawa T, Shimoyama Y, Kimura S, Takagi T. Characterization of the glutamyl endopeptidase from Staphylococcus aureus expressed in Escherichia coli. FEBS Journal. 2008;275:573–87. doi:10.1111/j.1742-4658.2007.06224.x.
  • Sugimoto S, Iwase T, Sato F, Tajima A, Shinji H, Mizunoe Y. Cloning, expression and purification of extracellular serine protease Esp, a biofilm-degrading enzyme from Staphylococcus epidermidis. J Appl Microbiol. 2011;111(6):1406–15. doi:10.1111/j.1365-2672.2011.05167.x.
  • Ohara-Nemoto Y, Ikeda Y, Kobayashi M, Sasaki M, Tajika S, Kimura S. Characterization and molecular cloning of a glutamyl endopeptidase from Staphylococcus epidermidis. Microb Pathog. 2002;33(1):33–41. doi:10.1006/mpat.2002.0515.
  • Chen C, Krishnan V, Makon K, Manne K, Narayana S, Schneewind O. Secreted proteases control autolysin-mediated biofilm growth of Staphylococcus aureus. J Biol Chem. 2013;288:29440–52.
  • Bispo P, Hofling-Lima A, Pignatari A. Characterization of ocular methicillin-resistant Staphylococcus epidermidis isolates belonging predominantly to clonal complex 2 subcluster II. J Clin Microbiol. 2014;52(5):1412–17. doi:10.1128/JCM.03098-13.
  • Sotozono C, Fukuda M, Ohishi M, Yano K, Origasa H, Saiki Y, Shimomura Y, Kinoshita S. Vancomycin ophthalmic ointment 1% for methicillin-resistant Staphylococcus aureus or methicillin-resistant Staphylococcus epidermidis infections: a case series. BMJ Open. 2013;3(1):e001206. doi:10.1136/bmjopen-2012-001206.
  • Cheung G, Rigby K, Wang R, Queck S, Braughton K, Whitney A, Teintze M, DeLeo F, Otto M. Staphylococcus epidermidis strategies to avoid killing by human neutrophils. PLoS Pathog. 2010;6(10):1–10. doi:10.1371/journal.ppat.1001133.
  • Peschel A, Otto M. Phenol-soluble modulins and staphylococcal infection. Nat Rev Microbiol. 2013;11:667–73.
  • Vandecandelaere I, Depuydt P, Nelis H, Coenye T. Protease production by Staphylococcus epidermidis and its effect on Staphylococcus aureus biofilms. Pathog Dis. 2014;70(3):321–31. doi:10.1111/2049-632X.12133.
  • Iwase T, Uehara Y, Shinji H, Tajima A, Seo H, Takada K, Agata T, Mizunoe Y. Staphylococcus epidermidis Esp inhibits Staphylococcus aureus biofilm formation and nasal colonization. Nature. 2010;465(7296):346–49. doi:10.1038/nature09074.
  • Thibodeaux B, Caballero A, Dajcs J, Marquart M, Engel L, O’Callaghan R. Pseudomonas aeruginosa protease IV: a corneal virulence factor of low immunogenicity. Ocul Immunol Inflamm. 2005;13(2–3):169–82. doi:10.1080/09273940490518937.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.